“Order intake for the third quarter was sequentially somewhat weaker. The development originated from a low activity level within the marine sector and generally longer decision processes for larger investment projects among our customers. We estimate that the demand during the fourth quarter will be unchanged to somewhat higher. The adjusted EBITA margin in the quarter was sequentially unchanged at 15.6 percent. In order to secure the profitability going forward and to strengthen our competitiveness we are today launching a programme. The programme comprises cost savings in sales and admin - generated by the new structure, a reduction of the number of manufacturing entities and that certain entities that have not developed as expected are lifted out of Alfa Laval’s new operating structure. The non-recurring cost is estimated to reach SEK 1.5 billion in total, of which SEK 1.1 billion is charged to the third quarter. Of these some SEK 600 million relate to write-offs for predominately step-up and goodwill and is a non-cash item. The program is expected to generate savings of SEK 300 million in sales and admin. Our on-going work with cost savings in manufacturing, within procurement as well as staffing, aimed at supporting the gross profit during a period of lower capacity utilisation continues in parallel. The work with implementing the new organisation is proceeding according to plan. More information on the organisation as well as the strategic direction will be given in connection with the Capital Markets Day on November 22. During the quarter the ballast water convention was ratified, which means that parts of the global merchant fleet will install cleaning systems during the next six years. The activity on the market is high, and the effect on order intake is expected in 2017.” Tom Erixon, President and CEO Summary: third quarter Order intake decreased by 14 percent* to SEK 7,540 (8,686) million. Net sales decreased by 12 percent* to SEK 8,581 (9,693) million. Adjusted EBITA**: SEK 1,339 (1,675) million. Adjusted EBITA margin**: 15.6 (17.3) percent. Result after financial items: SEK 93 (1,336) million. Net income: SEK -106 (988) million. Earnings per share: SEK -0,27 (2.34). Cash flow from operating activities: SEK 911 (1,369) million. Impact on adjusted EBITA of foreign exchange effects: SEK 107 (40) million. Impact on result after financial items of comparison distortion items: SEK -1,100 (-) million. Summary: first nine months Order intake decreased by 14 percent* to SEK 23,351 (27,676) million. Net sales decreased by 9 percent* to SEK 25,730 (28,941) million. Adjusted EBITA**: SEK 4,065 (5,060) million. Adjusted EBITA margin**: 15.8 (17.5) percent. Result after financial items: SEK 2,448 (4,054) million. Net income: SEK 1,696 (2,926) million. Earnings per share: SEK 4.00 (6.93). Cash flow from operating activities: SEK 3,054 (3,975) million. Impact on adjusted EBITA of foreign exchange effects: SEK 337 (370) million. Impact on result after financial items of comparison distortion items: SEK -1,100 (-) million. * Excluding currency effects. ** Alternative performance measures, defined on page 22. Outlook for the fourth quarter: “We expect that demand during the fourth quarter 2016 will be in line with or somewhat higher than in the third quarter.” Earlier published outlook (July 18, 2016): “We expect that demand during the third quarter 2016 will be in line with or somewhat lower than in the second quarter.” The interim report has been reviewed by the company’s auditors, see page 23 for the review report. For more information, please contact: Peter Torstensson Senior Vice President, Communications Phone: +46 46 36 72 31 Mobile: +46 709 33 72 31 peter.torstensson@alfalaval.com Gabriella Grotte Investor Relations Manager Phone: +46 46 36 74 82 Mobile: +46 709 78 74 82 gabriella.grotte@alfalaval.com Alfa Laval AB (publ) PO Box 73 SE-221 00 Lund Sweden Corporate registration number: 556587-8054 This information is information that Alfa Laval AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at CET 7.30 on October 25, 2016.
Alfa Laval AB (publ) Interim report July 1 - September 30,
Top 10 Most Recent News Articles
Charter Next Generation Unveils Gen 2 MDO-PE Films
Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...
Continue Reading
Purina Institute Highlights Nutritional Science at WSAVA 2026
A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...
Continue Reading
Community Banks Missing $106B Lending Opportunity?
A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...
Continue Reading
IWP and VYRE Unveil 'The Plug' for VBNGtv Content
Bringing Capital and Content Under One Roof There's something in the air as Itibari-Waynne & Partners (IWP) team up with the VYRE Network to crank out a fresh slate of content for VYRE Business News Global (VBNGtv). This partnership ain't just another splash in the buzzy world of digital media; it's like merging Wall Street with Hollywood. IWP, prepping to go full...
Continue Reading
Navigating Holiday Sweets: Healthy Balancing Acts
In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...
Continue Reading
Karoo Health Leaps Forward with New CCO Breton
Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...
Continue Reading
Cure Blindness Project's 770K Screenings for World Sight Day
Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...
Continue ReadingROKFORM’s Signal Card: A Wallet Tracker for All
The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...
Continue Reading
Epic Political Thriller Explores Humanity's Future
Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...
Continue Reading
Bob Evans' Protein Mac & Cheese: Practical Power Play
Has anyone else noticed just how fast the world spins when it comes to consumer trends these days? Bob Evans is hopping right on the protein bandwagon with its latest launch, a microwave-ready Protein Macaroni & Cheese that packs 18 grams of protein per serving. You gotta hand it to them for seizing opportunity when they see it. This one's not just about tossing a new...
Continue ReadingTop 5 Most Recently Viewed Articles
Bird Unveils Innovative E-Bike and Scooter Fleet for Cities
Enhancements in Micromobility: Bird's Latest Fleet Launch As the demand for smarter urban mobility continues to rise, Bird is taking significant strides in enhancing its vehicle offerings by introducing a new fleet of electric scooters and e-bikes. This expansion aims to cater to the growing number of individuals seeking efficient and sustainable alternatives to...
Continue Reading
Polestar Automotive's Class Action: Your Rights and Next Steps
Understanding the Polestar Automotive Class Action Polestar Automotive Holding UK PLC, widely recognized as an innovator in the electric performance car market, is currently facing a significant class action lawsuit. This legal action pertains to individuals and entities that bought or otherwise acquired Polestar shares during a defined period. If you're among those...
Continue Reading
Exploring the Growth and Dynamics of the Polyols Market
Overview of the Polyols Market The polyols market is poised for significant growth, expected to reach USD 21.59 billion by 2030, reflecting a compound annual growth rate (CAGR) of 5.1%. Polyols, characterized by their multiple hydroxyl (-OH) groups, play a vital role as feedstocks for the production of polyurethanes, a prevalent material in various industries....
Continue Reading
Cassava Sciences Advances Seizure Treatment Through New Patent
Innovative Treatment for Seizures by Cassava Sciences Cassava Sciences, Inc. (NASDAQ: SAVA), a biotech company at the forefront of developing treatments for central nervous system disorders, has made a significant stride in battling seizures linked to rare neurodevelopmental disorders. By entering into a license agreement with Yale University, Cassava is now authorized to...
Continue Reading
Innovative Partnership Launches Rapidise with $4M Funding
Transformative Launch of Rapidise Technology Pvt. Ltd. In an exciting development in the tech industry, Napino Tech Ventures Pvt. Ltd. and Teksun Microsys Pvt. Ltd. have unveiled Rapidise Technology Pvt. Ltd. with a robust seed funding of $4 million. This collaborative effort is set to revolutionize the design, engineering, and manufacturing processes of AI-enabled...
Continue Reading